SCHEMBL6069834

SCHEMBL6069834

C[C@@H]1CCCCN1CCn1ncc2c(NC(=O)Cc3ccc(OCc4ccccc4)cc3)cccc21

nearest known ligand 0.77

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 10/20 0.77
MCHR2 Q969V1 2/20 0.54
HRH3 Q9Y5N1 2/20 0.49
ITGA4 P13612 1/20 0.43
ITGB7 P26010 1/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
TP53 P04637 1/20 0.40
POLB P06746 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6070500 0.98 MCHR1 (0.75) MCHR1MCHR2HRH3ITGA4ITGB7
SCHEMBL6069418 0.87 MCHR1 (1.00) MCHR1MCHR2SMN1; SMN2
SCHEMBL6069463 0.85 MCHR1 (0.81) MCHR1MCHR2HRH3
SCHEMBL6070018 0.82 MCHR1 (0.87) MCHR1MCHR2
SCHEMBL6069326 0.78 MCHR1 (0.82) MCHR1MCHR2
SCHEMBL6070315 0.77 MCHR1 (0.81) MCHR1MCHR2MEN1KMT2ASMN1; SMN2
SCHEMBL6069577 0.75 MCHR1 (0.66) MCHR1MCHR2MEN1KMT2A
SCHEMBL6069561 0.75 MCHR1 (0.77) MCHR1MCHR2
SCHEMBL6070033 0.74 MCHR1 (0.77) MCHR1MCHR2KMT2A
SCHEMBL6069427 0.73 MCHR1 (0.74) MCHR1MCHR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7071182-B2 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor ABBOTT LABORATORIES (US) 2006-07-04 US claimed
US-20050277638-A1 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor ABBVIE INC. 2005-12-15 US claimed
US-20050137243-A1 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor ABBOTT LABORATORIES 2005-06-23 US claimed
US-7071182-B2 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor ABBOTT LABORATORIES (US) 2006-07-04 US disclosed
US-20050277638-A1 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor ABBVIE INC. 2005-12-15 US disclosed
US-20050137243-A1 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor ABBOTT LABORATORIES 2005-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050137243-A1 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor MCHR1, MCHR2, MC1R MCHR1 1/4885MCHR2 2/4885HRH3 196/4885
US-20050277638-A1 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor MCHR1, MCHR2, MC1R MCHR1 1/4885MCHR2 2/4885HRH3 196/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.